Recro Pharma, Inc. Uncategorized Contracts & Agreements
13 Contracts & Agreements
- Description of Securities (Filed With SEC on March 22, 2024)
- Description of Securities (Filed With SEC on March 1, 2022)
- Employee Matters Agreement, dated February 12, 2020, by and between Recro Pharma, Inc. and Baudax Bio, Inc (Filed With SEC on March 4, 2020)
- Description of Securities (Filed With SEC on March 4, 2020)
- Employee Matters Agreement, dated as of November 20, 2019, by and between Recro Pharma, Inc. and Baudax Bio, Inc (Filed With SEC on November 26, 2019)
- Tax Matters Agreement, dated as of November 20, 2019, by and between Recro Pharma, Inc. and Baudax Bio, Inc (Filed With SEC on November 26, 2019)
- Product Agreement, dated July 14, 2017, by and between Patheon UK Limited and Recro Ireland Limited (Filed With SEC on August 11, 2017)
- Licensing Agreement, dated June 30, 2017, by and between Cornell University and Recro Pharma, Inc (Filed With SEC on August 11, 2017)
- SUPPLEMENTAL AGREEMENT (Filed With SEC on August 14, 2015)
- AMENDMENT NO. 1 TO THEEMPLOYMENT AGREEMENT Between Recro Pharma, Inc. and [ ] (Filed With SEC on December 19, 2014)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES... (Filed With SEC on November 29, 2013)
- EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on November 29, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES... (Filed With SEC on November 29, 2013)
